Ariad Pharmaceuticals, Inc (NASDAQ:ARIA) witnessed volume of 13.72 million shares during last trade however it holds an average trading capacity of 3.01 million shares. ARIA last trade opened at $10.72 reached intraday low of $10.64 and went +5.47% up to close at $10.99.
ARIA has a market capitalization $1.46 billion and an enterprise value at $1.39 billion. Trailing twelve months price to sales ratio of the stock was 56.68 while price to book ratio in most recent quarter was 54.41. In profitability ratios, operating profit margin in past twelve months appeared at -241.53%.
The company made a return on asset of -43.08% in past twelve months and return on equity of -327.33% for similar period. In the period of trailing 12 months it generated revenue amounted to $25.76 million gaining $0.20 revenue per share.
According to preceding quarter balance sheet results, the company had $86.32 million cash in hand making cash per share at 0.65. The total of $13.03 million debt was there putting a total debt to equity ratio 48.56. Moreover its current ratio according to same quarter results was 4.28 and book value per share was 0.20.
Looking at the trading information, the stock price history displayed that its S&P500 52 Week Change illustrated -2.26% where the stock current price exhibited down beat from its 50 day moving average price of $11.21 and remained up from its 200 Day Moving Average price of $10.44.
ARIA holds 132.85 million outstanding shares with 127.13 million floating shares where insider possessed 3.63% and institutions kept 59.30%.
No comments:
Post a Comment